{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:46:53Z","timestamp":1782492413184,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673433"],"award-info":[{"award-number":["81673433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473205"],"award-info":[{"award-number":["81473205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Project of Guangdong Province","award":["2015B020232009"],"award-info":[{"award-number":["2015B020232009"]}]},{"name":"Major Project of Guangdong Province","award":["2014B020210003"],"award-info":[{"award-number":["2014B020210003"]}]},{"name":"Major Project of Guangdong Province","award":["2013B090700010"],"award-info":[{"award-number":["2013B090700010"]}]},{"name":"Major Project of Platform Construction Education Department of Guangdong Province","award":["2014GKPT002"],"award-info":[{"award-number":["2014GKPT002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.mce.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T07:53:20Z","timestamp":1519890800000},"page":"137-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy"],"prefix":"10.1016","volume":"474","author":[{"given":"Luping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinzi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2018.02.020_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.phrs.2010.07.003","article-title":"Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?","volume":"62","author":"Balakumar","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2018.02.020_bib2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.febslet.2012.02.014","article-title":"Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6","volume":"586","author":"Cai","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2018.02.020_bib3","first-page":"1","article-title":"Inhibition of STAT3 phosphorylation by sulforaphane reduces adhesion molecule expression in vascular endothelial cell","author":"Cho","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.mce.2018.02.020_bib5","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.mce.2018.02.020_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1398-9995.2011.02549.x","article-title":"PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model","volume":"66","author":"Datta","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.mce.2018.02.020_bib7","doi-asserted-by":"crossref","first-page":"15969","DOI":"10.1074\/jbc.M114.564252","article-title":"Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells","volume":"289","author":"Don-Doncow","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.02.020_bib8","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/bph.13091","article-title":"The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1","volume":"172","author":"Feng","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2018.02.020_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2005.02.003","article-title":"Many good reasons to have STAT3 in the heart","volume":"107","author":"Hilfiker-Kleiner","year":"2005","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.mce.2018.02.020_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tcm.2005.05.002","article-title":"STAT3-mediated activation of myocardial capillary growth","volume":"15","author":"Hilfiker-Kleiner","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.mce.2018.02.020_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A\u00a0cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mce.2018.02.020_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2008.10.019","article-title":"Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun\/c-Fos in cardiac fibroblasts","volume":"46","author":"Huang","year":"2009","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2018.02.020_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cell.2004.11.017","article-title":"Activating the PARP-1 sensor component of the Groucho\/TLE1 corepressor complex mediates a CaMKinase II delta-dependent neurogenic gene activation pathway","volume":"119","author":"Ju","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.mce.2018.02.020_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ncb1638","article-title":"Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation","volume":"9","author":"Kanai","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mce.2018.02.020_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1073\/pnas.97.1.315","article-title":"Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy","volume":"97","author":"Kunisada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2018.02.020_bib16","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.00032.2009","article-title":"JAK redux: a second look at the regulation and role of JAKs in the heart","volume":"297","author":"Kurdi","year":"2009","journal-title":"Am J Physiol-Heart C"},{"key":"10.1016\/j.mce.2018.02.020_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1751-7133.2010.00175.x","article-title":"Deciphering STAT3 signaling in the heart: plasticity and vascular inflammation","volume":"16","author":"Kurdi","year":"2010","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.mce.2018.02.020_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do?","volume":"109","author":"Levy","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2018.02.020_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jphs.2016.03.010","article-title":"PKCzeta interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy","volume":"132","author":"Li","year":"2016","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.mce.2018.02.020_bib20","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3892\/ijo.2016.3728","article-title":"STAT3 as a potential therapeutic target in ALDI(+) and CD44(+)\/CD24(+) stem cell-like pancreatic cancer cells","volume":"49","author":"Lin","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mce.2018.02.020_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2014.05.010","article-title":"AG-690\/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy","volume":"392","author":"Liu","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.02.020_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbrc.2014.01.045","article-title":"Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1","volume":"444","author":"Liu","year":"2014","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.mce.2018.02.020_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.trsl.2015.06.003","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway","volume":"166","author":"Liu","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.mce.2018.02.020_bib24","first-page":"3027","article-title":"The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy","volume":"1863","author":"Lu","year":"2016","journal-title":"BBA-Mol Cell Res."},{"key":"10.1016\/j.mce.2018.02.020_bib25","doi-asserted-by":"crossref","first-page":"28675","DOI":"10.1074\/jbc.M115.661611","article-title":"Poly(ADP-ribosyl)ation of FOXP3 protein mediated by PARP-1 protein regulates the function of regulatory T cells","volume":"290","author":"Luo","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.02.020_bib26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1074\/jbc.M110.157768","article-title":"PARP-14 functions as a transcriptional switch for STAT6-dependent gene activation","volume":"286","author":"Mehrotra","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.02.020_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/imm.12515","article-title":"Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development","volume":"146","author":"Mehrotra","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.mce.2018.02.020_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0008-6363(00)00138-3","article-title":"Activation of JAK\/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction","volume":"47","author":"Negoro","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2018.02.020_bib29","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/MCB.01746-07","article-title":"Regulation of transcription factor NFAT by ADP-ribosylation","volume":"28","author":"Olabisi","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2018.02.020_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","article-title":"Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors","volume":"25","author":"Pacher","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.mce.2018.02.020_bib31","doi-asserted-by":"crossref","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","article-title":"Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction","volume":"294","author":"Phrommintikul","year":"2008","journal-title":"Am J Physiol-Heart C"},{"key":"10.1016\/j.mce.2018.02.020_bib32","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M506162200","article-title":"Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD(+) depletion and reduced Sir2 alpha deacetylase activity","volume":"280","author":"Pillai","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.02.020_bib33","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","article-title":"Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy","volume":"291","author":"Pillai","year":"2006","journal-title":"Am J Physiol-Heart C"},{"key":"10.1016\/j.mce.2018.02.020_bib34","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cellsig.2006.01.013","article-title":"Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET)","volume":"18","author":"Prinz","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.mce.2018.02.020_bib35","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/0008-5472.CAN-13-2433","article-title":"HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer","volume":"74","author":"Rath","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.02.020_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0008-6363(00)00076-6","article-title":"Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways","volume":"47","author":"Ruwhof","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2018.02.020_bib37","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/sj.onc.1210156","article-title":"Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice","volume":"26","author":"Tong","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2018.02.020_bib38","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/emboj.2008.61","article-title":"A\u00a0synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor","volume":"27","author":"Turner","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2018.02.020_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation","volume":"82","author":"Wen","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mce.2018.02.020_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7150\/ijbs.4.184","article-title":"STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMX","volume":"4","author":"Willey","year":"2008","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.mce.2018.02.020_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvp285","article-title":"Role of nuclear unphosphorylated STAT3 in angiotensin \u2161 type 1 receptor-induced cardiac hypertrophy","volume":"85","author":"Yue","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2018.02.020_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/FJC.0000000000000404","article-title":"STAT3 suppression is involved in the protective effect of SIRT6 against cardiomyocyte hypertrophy","volume":"68","author":"Zhang","year":"2016","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.mce.2018.02.020_bib43","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/pr050456l","article-title":"Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats","volume":"5","author":"Zhou","year":"2006","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.mce.2018.02.020_bib44","article-title":"Dancing rhinos in stilettos: the amazing saga of the genomic and nongenomic actions of STAT3 in the heart","volume":"2","author":"Zouein","year":"2014","journal-title":"JAK-STAT"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718300807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718300807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:06:49Z","timestamp":1759586809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720718300807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":43,"alternative-id":["S0303720718300807"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2018.02.020","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}